• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    180.08 0.00(0.00%) Apr 24, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 599,476   555,146   512,495   566,616  
    Cost of Revenue49,439  51,858  39,626  32,939  
    Gross Profit 550,037   503,288   472,869   533,677  
    Operating Expenses
    Research Development129,110  100,661  92,554  191,457  
    Selling General and Administrative183,776  157,665  159,477  129,291  
    Non Recurring33,456  8,303  1,989  3,426  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 203,695   236,659   218,849   209,503  
    Income from Continuing Operations
    Total Other Income/Expenses Net2,195  205  512  3,471  
    Earnings Before Interest And Taxes205,890  236,864  219,361  212,974  
    Interest Expense549  655  715  1,063  
    Income Before Tax205,341  236,209  218,646  211,911  
    Income Tax Expense52,009  58,478  52,151  52,557  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops153,332  177,731  166,495  159,354  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 153,332   177,731   166,495   159,354  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 153,332   177,731   166,495   159,354  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.